These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 10936799

  • 21. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A, Kumar SR, Ackley W, Soiefer L, Chun J, Singh P, Grossman E, Matalon A, Holzman RS, Meijers B, Lowenstein J.
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [Abstract] [Full Text] [Related]

  • 22. Review on uremic toxins: classification, concentration, and interindividual variability.
    Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W, European Uremic Toxin Work Group (EUTox).
    Kidney Int; 2003 May; 63(5):1934-43. PubMed ID: 12675874
    [Abstract] [Full Text] [Related]

  • 23. The optimal timing of hemoperfusion component in combined hemodialysis-hemoperfusion treatment for uremic toxins removal.
    Li J, Li D, Xu Y, Wang A, Xu C, Yu C.
    Ren Fail; 2015 Feb; 37(1):103-7. PubMed ID: 25421427
    [Abstract] [Full Text] [Related]

  • 24. Generation, clearance, toxicity, and monitoring possibilities of unaccounted uremic toxins for improved dialysis prescriptions.
    Atherton JG, Hains DS, Bissler J, Pendley BD, Lindner E.
    Am J Physiol Renal Physiol; 2018 Oct 01; 315(4):F890-F902. PubMed ID: 29537310
    [Abstract] [Full Text] [Related]

  • 25. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 26. Classification of Uremic Toxins and Their Role in Kidney Failure.
    Rosner MH, Reis T, Husain-Syed F, Vanholder R, Hutchison C, Stenvinkel P, Blankestijn PJ, Cozzolino M, Juillard L, Kashani K, Kaushik M, Kawanishi H, Massy Z, Sirich TL, Zuo L, Ronco C.
    Clin J Am Soc Nephrol; 2021 Dec 01; 16(12):1918-1928. PubMed ID: 34233920
    [Abstract] [Full Text] [Related]

  • 27. What is new in uremic toxicity?
    Vanholder R, Van Laecke S, Glorieux G.
    Pediatr Nephrol; 2008 Aug 01; 23(8):1211-21. PubMed ID: 18324423
    [Abstract] [Full Text] [Related]

  • 28. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.
    Lesaffer G, De Smet R, Lameire N, Dhondt A, Duym P, Vanholder R.
    Nephrol Dial Transplant; 2000 Jan 01; 15(1):50-7. PubMed ID: 10607767
    [Abstract] [Full Text] [Related]

  • 29. Improving removal of protein-bound retention solutes.
    Bammens B, Evenepoel P.
    Contrib Nephrol; 2005 Jan 01; 149():175-184. PubMed ID: 15876842
    [Abstract] [Full Text] [Related]

  • 30. Uremic toxicity: urea and beyond.
    Depner TA.
    Semin Dial; 2001 Jan 01; 14(4):246-51. PubMed ID: 11489197
    [Abstract] [Full Text] [Related]

  • 31. Role of dialysis technology in the removal of uremic toxins.
    Davenport A.
    Hemodial Int; 2011 Oct 01; 15 Suppl 1():S49-53. PubMed ID: 22093601
    [Abstract] [Full Text] [Related]

  • 32. [Uraemic toxins and cardiovascular diseases].
    Oko A, Pawlaczyk K, Czekalski S.
    Przegl Lek; 2005 Oct 01; 62 Suppl 2():7-10. PubMed ID: 16623109
    [Abstract] [Full Text] [Related]

  • 33. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B, Grujić-Adanja G.
    Srp Arh Celok Lek; 1997 Oct 01; 125(5-6):163-7. PubMed ID: 9265238
    [Abstract] [Full Text] [Related]

  • 34. Urea kinetics evaluation of hemodialysis and CAPD patients.
    Acchiardo SR, Kraus AP, LaHatte G, Kaufman PA, Adkins D, Moore LW.
    Adv Perit Dial; 1992 Oct 01; 8():55-8. PubMed ID: 1361852
    [Abstract] [Full Text] [Related]

  • 35. What we have learned about uremia from peritoneal dialysis.
    Nolph KD.
    ASAIO J; 1992 Oct 01; 38(4):745-50. PubMed ID: 1450467
    [Abstract] [Full Text] [Related]

  • 36. A review of urea and creatinine kinetics in predicting CAPD outcome.
    Campbell D, Fritsche C, Brandes J.
    Adv Perit Dial; 1992 Oct 01; 8():79-83. PubMed ID: 1361859
    [Abstract] [Full Text] [Related]

  • 37. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.
    Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y.
    Am J Kidney Dis; 2005 Sep 01; 46(3):512-9. PubMed ID: 16129214
    [Abstract] [Full Text] [Related]

  • 38. Uremic toxins and peritoneal dialysis.
    Lameire N, Vanholder R, De Smet R.
    Kidney Int Suppl; 2001 Feb 01; 78():S292-7. PubMed ID: 11169029
    [Abstract] [Full Text] [Related]

  • 39. Protection of Residual Renal Function and Nutritional Treatment: First Step Strategy for Reduction of Uremic Toxins in End-Stage Kidney Disease Patients.
    Cupisti A, Bolasco P, D'Alessandro C, Giannese D, Sabatino A, Fiaccadori E.
    Toxins (Basel); 2021 Apr 19; 13(4):. PubMed ID: 33921862
    [Abstract] [Full Text] [Related]

  • 40. Individualized use of hemodialysis and peritoneal dialysis.
    Honkanen E.
    Scand J Urol Nephrol; 1993 Apr 19; 27(3):289-93. PubMed ID: 8290905
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.